BUDGET IMPACT OF FARICIMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE RELATED DEGENERATION IN CANADA

被引：0
|
作者：
Buhrer, C. [1 ]
Diles, D. [2 ]
机构：
[1] F Hoffmann La Roche, Basel, Switzerland
[2] Hoffmann La Roche Ltd, Mississauga, ON, Canada
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE76
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] Burden of illness of neovascular age-related macular degeneration in Canada
    Cruess, Alan
    Zlateva, Gergana
    Xu, Xiao
    Rochon, Sophie
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2007, 42 (06): : 836 - 843
  • [42] Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
    Larsen, Helene O.
    Grauslund, Jakob
    Vergmann, Anna S.
    [J]. OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2253 - 2264
  • [43] Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice
    Guymer, Robyn
    Bailey, Clare
    Chaikitmongkol, Voraporn
    Chakravarthy, Usha
    Chaudhary, Varun
    Finger, Robert P.
    Gallego-Pinazo, Roberto
    Chuan, Adrian Koh Hock
    Ishida, Susumu
    Loevestam-Adrian, Monica
    Parravano, Mariacristina
    Pinto, Jose D. Luna
    Schmitz-Valckenberg, Steffen
    Sheth, Veeral
    Souied, Eric H.
    Chi, Gloria C.
    Gilberg, Frank
    Glittenberg, Carl
    Scheidl, Stefan
    Bengus, Monica
    [J]. OPHTHALMOLOGY SCIENCE, 2024, 4 (03):
  • [44] Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
    Aljundi, Wissam
    Munteanu, Cristian
    Seitz, Berthold
    Abdin, Alaa Din
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2867 - 2874
  • [45] THE BURDEN OF DISEASE OF DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN HONDURAS, EL SALVADOR, & DOMINICAN REPUBLIC
    Hidalgo, J.
    Santos, M.
    Deras, P.
    Castro, A.
    Flores, M.
    Roi, R.
    Gonzales, A.
    Asilis Mera, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S160 - S160
  • [46] Change in Therapy of Neovascular Age-Related Macular Degeneration, Diabetic Maculopathy and Macular Edema after Retinal Vein Occlusion
    Grueb, Matthias
    Lamprakis, Ioannis
    Reichel, Christoph
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2019, 236 (07) : 885 - 891
  • [47] Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration
    Khanani, Arshad M.
    Guymer, Robyn H.
    Basu, Karen
    Boston, Heather
    Heier, Jeffrey S.
    Korobelnik, Jean-Francois
    Kotecha, Aachal
    Lin, Hugh
    Silverman, David
    Swaminathan, Balakumar
    Willis, Jeffrey R.
    Yoon, Young Hee
    Quezada-Ruiz, Carlos
    [J]. OPHTHALMOLOGY SCIENCE, 2021, 1 (04):
  • [48] Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration
    Aldhanhani, Aisha A.
    Azzam, Ola A.
    AlAli, Sahar H.
    Almasri, Khaled G.
    Aljneibi, Shaikha H.
    Pichi, Francesco
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [49] Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration
    Maiko Maruyama-Inoue
    Yasuo Yanagi
    Tatsuya Inoue
    Kazuaki Kadonosono
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 589 - 599
  • [50] Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab
    Raslan, Walid
    Younis, Saad
    Fabozzi, Lorenzo
    Hassan, Islam
    Palmieri, Filomena
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
12345